Cantel Medical Corp. (NYSE:CMD) has been given an average broker rating score of 2.50 (Hold) from the two analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. Cantel Medical’s rating score has declined by 11.1% in the last 90 days as a result of various analysts’ ratings changes.

Analysts have set a 1-year consensus price target of $115.00 for the company and are expecting that the company will post $0.62 EPS for the current quarter, according to Zacks. Zacks has also assigned Cantel Medical an industry rank of 152 out of 255 based on the ratings given to its competitors.

Shares of CMD stock traded up $0.17 during mid-day trading on Tuesday, reaching $96.62. 206,473 shares of the company’s stock traded hands, compared to its average volume of 204,563. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.44 and a quick ratio of 1.52. Cantel Medical has a 12 month low of $83.24 and a 12 month high of $130.92. The company has a market cap of $3.99 billion, a price-to-earnings ratio of 41.56 and a beta of 1.08.

About Cantel Medical

Cantel Medical Corp. provides infection prevention products and services for the healthcare market worldwide. The company operates through four segments: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Featured Story: Google Finance Portfolio Tips and Tricks

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with's FREE daily email newsletter.